======= ABHD17B ======= == Gene Information == * **Official Symbol**: ABHD17B * **Official Name**: abhydrolase domain containing 17B, depalmitoylase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51104|51104]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5VST6|Q5VST6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ABHD17B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ABHD17B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617943|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Hydrolyzes fatty acids from S-acylated cysteine residues in proteins (PubMed:26701913). Has depalmitoylating activity towards DLG4/PSD95 (PubMed:26701913). Has depalmitoylating activity towards GAP43 (By similarity). Has depalmitoylating activity towards MAP6 (By similarity). Has depalmitoylating activity towards NRAS (PubMed:26701913). {ECO:0000250|UniProtKB:Q7M759, ECO:0000269|PubMed:26701913}. |Abhydrolase 5| |Abhydrolase 6| |Peptidase S9| |anchored component of postsynaptic recycling endosome membrane| |anchored component of postsynaptic density membrane| |negative regulation of protein localization to microtubule| |regulation of protein localization to microtubule| |protein depalmitoylation| |palmitoyl-(protein) hydrolase activity| |macromolecule depalmitoylation| |positive regulation of protein localization to endosome| |regulation of dendritic spine maintenance| |regulation of protein localization to endosome| |lipoprotein catabolic process| |regulation of protein localization to synapse| |protein palmitoylation| |protein deacylation| |macromolecule deacylation| |recycling endosome membrane| |protein lipidation| |lipoprotein biosynthetic process| |regulation of postsynapse organization| |negative regulation of cellular protein localization| |lipoprotein metabolic process| |dendritic spine| |protein acylation| |regulation of synapse organization| |regulation of synapse structure or activity| |positive regulation of cellular protein localization| |glutamatergic synapse| |regulation of cellular protein localization| |cell junction| |protein catabolic process| |regulation of plasma membrane bounded cell projection organization| |regulation of cell projection organization| |regulation of cellular localization| |regulation of protein localization| |macromolecule catabolic process| |organonitrogen compound catabolic process| |organonitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |organic substance catabolic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-2.14| |[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|-1.87| |[[:results:exp187|proTAME 5μM R04 exp187]]|1.73| |[[:results:exp133|MKC9989 10μM R03 exp133]]|1.84| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|2| |[[:results:exp177|Apcin 25μM plus proTAME 2μM R04 exp177]]|2.3| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11215 * **Expression level (log2 read counts)**: 6.02 {{:chemogenomics:nalm6 dist.png?nolink |}}